Minimally Invasive BPH Treatment: Best Fits 2026

Best default to discuss: Rezum for suitable men prioritizing tissue reduction without prostate resection. Best implant-based option: UroLift. Best temporary-device option: iTind. This 2026 minimally invasive BPH treatment comparison explains those choices, prostate artery embolization, and Aquablation; your prostate anatomy and treatment goals determine which belongs on your shortlist.

Why this matters

Benign prostatic hyperplasia, or BPH, is non-cancerous prostate enlargement. It can contribute to weak flow, difficulty starting urination, incomplete emptying, urgency, and waking at night. However, prostate size alone does not explain every urinary symptom.

The best procedure treats the cause of your symptoms while respecting your priorities. That means distinguishing prostate obstruction from bladder dysfunction, infection, urethral narrowing, and other conditions before choosing treatment. The enlarged prostate treatment options guide provides broader context for that decision.

AIME is a fit for men seeking physician-led BPH care in Edmonton and a discussion of Rezum water vapor therapy. A consultation should establish whether a procedure is appropriate—not simply select a procedure from a menu.

What makes the best minimally invasive BPH treatment?

Use these criteria to assess your 2026 shortlist before comparing individual treatments:

• Anatomical fit: Prostate size, shape, and an obstructing middle lobe can change eligibility.
• Meaningful symptom relief: Better flow matters, but urgency and nighttime urination also need assessment.
• Sexual-function priorities: Discuss ejaculation separately from erections; they are different outcomes.
• Recovery burden: Ask about anaesthesia, catheter use, discomfort, and time away from usual activities.
• Durability: Compare the possibility of further medication or another procedure, not just early improvement.
• Treatment setting: An office-based procedure, interventional radiology treatment, and operating-room procedure involve different preparation.

No treatment wins every criterion. A short procedure is not automatically a short recovery, and preserving ejaculation does not mean a procedure carries no sexual risks.

Minimally invasive BPH treatments at a glance

These are decision categories, not promises of equivalent results. Aquablation belongs in the comparison because patients often encounter it alongside less invasive options, but it is not an office-based treatment.

1. Rezum: best for tissue reduction without prostate resection

Rezum delivers water vapour into selected areas of prostate tissue. The treated tissue is gradually absorbed, reducing obstruction rather than mechanically holding the channel open. Improvement takes time; this is not an immediate-relief procedure.

The American Urological Association BPH guideline includes water vapour thermal therapy as an option for prostates of 30–80 g. That guideline range helps frame selection, but it does not replace an assessment of your anatomy, urinary retention, and bladder function. Treatment outside a guideline's stated range requires a separate evidence discussion.

Rezum pros:

• Treats obstructing tissue without surgical resection.
• Can address selected obstructing middle-lobe anatomy.
• Is an option when preserving ejaculation is a priority.
• Does not leave permanent implants behind.

Rezum cons:

• Temporary swelling can initially worsen urinary symptoms.
• A catheter is commonly needed during early recovery.
• Symptoms can persist, and additional treatment remains possible.

Best for: A suitable patient who accepts gradual improvement and short-term urinary management in exchange for avoiding prostate resection.

AIME offers Rezum water vapor therapy as part of its BPH care. Ask how your anatomy supports that choice and what the catheter plan involves.

Verdict: Hold until prostate assessment confirms suitability; Rezum is the default discussion here, not a universal winner.

2. UroLift: best for an implant-based approach

UroLift, also called prostatic urethral lift, places implants that pull obstructing prostate tissue away from the urethra. It opens the channel without removing or thermally destroying the targeted tissue. The implants remain in place.

The American Urological Association guideline describes prostatic urethral lift for prostates of 30–80 g, with verification that an obstructive middle lobe is absent. Published studies and device indications do not always use identical selection criteria. Ask which evidence supports the proposed approach for your anatomy rather than assuming every enlarged prostate qualifies.

UroLift pros:

• Does not remove prostate tissue.
• Offers an approach focused on preserving sexual function.
• Avoids the gradual tissue-absorption mechanism used by Rezum.

UroLift cons:

• Permanent implants remain in the prostate.
• Prostate shape and size restrict suitability.
• Further treatment can be necessary if obstruction persists or returns.

Best for: A suitable patient who prefers mechanical opening of the urinary channel and accepts permanent implants.

Ask how the implants would affect any later prostate procedure or imaging assessment. Planning for future care belongs in the initial decision, even when your immediate priority is easier urination.

Verdict: Hold until anatomy and the implications of permanent implants are clear.

3. iTind: best for a temporary-device approach

iTind is a temporarily implanted nitinol device placed within the prostatic urethra. It applies pressure to reshape the outlet, then is removed. Unlike UroLift, it does not leave permanent implants behind.

This distinction is useful when a retained device is a concern, but it does not establish that iTind is suitable for every prostate. Selection depends on prostate dimensions, outlet anatomy, and the evidence supporting treatment in that patient group.

iTind pros:

• The device is removed after treatment.
• Does not use tissue resection or thermal ablation.
• Offers an option for selected patients prioritizing preservation of sexual function.

iTind cons:

• Requires a separate device-removal step.
• The temporary device can cause discomfort and urinary symptoms.
• Long-term evidence is less mature than for established surgical procedures.

Best for: A selected patient who wants to avoid both permanent implants and thermal tissue treatment.

For a 2026 consultation, ask specifically about local availability, clinician experience, and the evidence for your prostate anatomy. Do not interpret inclusion in a comparison as confirmation that a clinic offers the procedure.

Verdict: Hold until selection criteria and the follow-up plan support this temporary-device approach.

4. Prostate artery embolization: best for an arterial approach

Prostate artery embolization, or PAE, uses a catheter introduced through an artery to deliver particles into the prostate's blood supply. Reducing that blood supply causes the prostate to shrink over time. An interventional radiologist performs the procedure.

PAE avoids treating the prostate through the urethra, but it still involves arterial access, imaging, contrast, and technical risks. A discussion with urology remains important because urinary symptoms need a diagnosis before referral for embolization.

Prostate artery embolization pros:

• Does not require transurethral prostate resection.
• Provides a distinct option for selected patients seeking an arterial approach.
• Can be considered when other procedural choices do not fit a patient's circumstances.

Prostate artery embolization cons:

• Arterial anatomy can make treatment technically difficult.
• Non-target embolization can injure tissue outside the prostate.
• Symptom relief and relief of obstruction are not equivalent to those of every surgical alternative.

Best for: A selected patient whose urologist and interventional radiologist agree that an arterial approach fits the diagnosis and risk profile.

Ask whether bladder weakness, rather than prostate obstruction alone, contributes to your symptoms. Shrinking the prostate does not necessarily restore bladder function.

Verdict: Hold until both urinary assessment and arterial suitability support embolization.

5. Aquablation: best for operating-room tissue removal

Aquablation uses ultrasound-guided planning and a waterjet to remove prostate tissue. It differs fundamentally from implant placement, temporary reshaping, and gradual tissue shrinkage. It is a surgical procedure performed with anaesthesia.

For patients comparing options in 2026, the key distinction is treatment intensity. Aquablation offers tissue removal, but it should not be presented as interchangeable with an office-based minimally invasive procedure.

Aquablation pros:

• Removes obstructing prostate tissue directly.
• Uses ultrasound guidance to plan the treatment area.
• Allows a discussion of ejaculation preservation alongside the need for tissue removal.

Aquablation cons:

• Requires anaesthesia and an operating-room setting.
• Bleeding and postoperative catheter management require planning.
• Preserved ejaculation is not guaranteed.

Best for: A patient whose assessment supports surgical tissue removal and who accepts the associated recovery and procedural risks.

Ask why Aquablation is preferred over other tissue-removing operations in your case. The answer should address anatomy, bleeding considerations, sexual-function goals, and the clinician's experience—not simply the equipment used.

Verdict: Hold until the need for surgical tissue removal is established.

How this ranking works

This 2026 ranking organizes treatments by their mechanism and the patient preference each addresses. It is not a claim that Rezum produces the strongest results for every prostate or that later entries are inferior treatments.

The comparison uses the criteria above: anatomical fit, symptom relief, sexual-function priorities, recovery, durability, and setting. American Urological Association guidance informs the stated prostate-size criteria; individual eligibility requires clinical assessment.

Here, Hold means discuss the option after diagnosis. It does not mean delay care for urinary retention, recurrent infection, or other complications.

Which treatment should you choose?

Start with Rezum as a discussion option if you want tissue reduction without resection and your assessment supports it. Choose UroLift as a discussion option if an implant-based approach fits your anatomy and preferences. Consider iTind when avoiding permanent implants is a specific priority.

PAE needs a joint discussion of urinary obstruction and arterial treatment. Aquablation belongs on the shortlist when your clinician recommends surgical tissue removal rather than an office-based intervention.

Bring these questions to your appointment:

• What evidence shows that prostate obstruction causes my symptoms?
• Does my prostate have an obstructing middle lobe?
• What changes should I expect in ejaculation and erections?
• Will I need a catheter, and who manages problems after treatment?
• What is the plan if symptoms do not improve?

AIME provides men's sexual health care, including BPH treatment, in Edmonton. Discuss your urinary symptoms and sexual-function priorities together rather than choosing a procedure in isolation.

Measure symptoms before judging results

The International Prostate Symptom Score, or IPSS, measures urinary symptom severity on a scale of 0–35 points. Scores of 0–7 points describe mild symptoms, 8–19 points moderate symptoms, and 20–35 points severe symptoms. It records symptom burden; it does not diagnose the cause.

For your 2026 treatment discussion, record both the score and the symptom that matters most to you. Better flow and fewer nighttime bathroom visits are different goals, and bladder-related symptoms can remain after obstruction improves.

Your clinician can combine symptom scoring with examination, urine testing, assessment of bladder emptying, and other investigations when indicated. Do not use a symptom score alone to choose a procedure.

FAQ

One last thing

A better urinary stream does not guarantee a quieter bladder. Longstanding obstruction and separate bladder conditions can leave urgency or nighttime urination after a technically successful prostate procedure.

Before consenting, name your main goal: easier emptying, fewer bathroom trips, avoiding medication, or preserving ejaculation. Then ask which part of that goal the proposed treatment addresses—and which part needs a separate plan. That question is more useful than asking which procedure ranks first.

Related guides

• Erectile dysfunction treatment options
• Non-surgical treatments for Peyronie's disease